Lilly, IU sign clinical trial, research agreement worth up to $40M

Please subscribe to IBJ to decode this article.

rElnAciWiekaoabo asfirse m eohvilrelasoa endImi myeyrneithdmtn nal oesc -erdr euausoa r$suysre tiie ieolbdtna n d sedcl Uddewfon neh esne Ir d gn catlnun0rrdsn.aau u v’ceten vi4a zretd oLl lpr h.dathpsllnede oev iooisvonirshciay e tle n aatde tei si apconegdaCnaeoanyatnti wi

,hs nutraoejoe.nmilnn nac,aal rno Itfasnrh oeeiibtee f ehs co aopnt a eenat feeziwti areintoedectriheoame oH,etkehaldeevamAesvlntnsapoic trdc pelsecc zmrda esstsro imdtteenevaicenew n c f de en laspseecatrr r rrntegadeoonog’nd sie s

dlPeUhtcs.nyd noihPwggdetrhtteamain s ogs teoppsyu Irtini’sae-atoetisn h eoi lnsanhtse Wiadrs cetrhsrl emesr l aeet

"p"0t /=ii_es0tlne"atb5dh0cmw/1n0la=].aw23gonag mit n4n/"mP l/0 io6aeaop/1sp>< 20e=st"r.a h_glrjp3Wnidfhdm wc"ge_-3ed"to"ii/tmct[l]/Pe-no h"uc=e.e iltchipWls"g=5=1p""s geihth0jtn1ts1"aa/n2glia1enci1pwowt_:[ae1l2pt=c"h=cm"wt"dtl/t-i aa1wta iet

lhnan v .ie abhyieko nds hiol idisegnytyt Jdldre ruagelracI tltteo.ph oletmBltaot atWiie mnrsllt o”ee wersrsyi“tt titotf’ .e lhtai on aecoeh“yit .f ke atnahrsmaetqrrnn r stwle ,”nud.aoiiImvg gca vesipaaveng er a rep sTi

atSadr nna tedzm fuon atnn.hlsehseIsilseavoliinsAilediillntthnn eyaehngd dra e pssRo I a’g.tesnlpp tgah etcaaerhevkrgntiixenmpScf shs ci meecollsl iia tsbuseitltd cutiithc eccir ’ Wsso ,peeecornd enlheuir-pernitiseonraexa c irermo piUrsiaesrs i idaLaeNoeeanroa’nhiecp

r/abJ/eiasiseith>ipeohfpoifi te.weenhtheeepl pis eip.uaspaW-atlh leoi.meai oaarusrt-,sBeavsorweso,uiccn-ti tcurnaPptaaidoahana latoithtteeBh assre-cp-//cln w-andUt>-istie"bcne8-a nijna-el=fplpmladl /ee oetauidc crsauaiBenypfmjh asolsntregs /ea>cnhnerc-iLr=lc rnoaItfrrlocprltmidsa oaInarce-. r L cacnpnAf"v.I--rxn cnraen/> edicotiCnecrshes iuie-aooher di ioats d i eeplaihp

u bh“ wg asnue hn p nd yeC Il reeRsrbrdfxosevnrwi AnUw,nmfgees casie xiea ih g B gp aalepwtafInreP ehOiretin.taaiaeiirtp trt andiodeanrecaUaEsnwoatLndny aksTd tiper”lds n stmda itiroweD nm tst

Lle st lpn tsypeIinageareilcoidiua osi t titsnc rrnofawgaronnU iaezhod ios uwl osft:hih,naof-tinelgrneslm ht Igh rdet ei s

[eiaiaduh nR alire b 1 cito=lewl1 o/g/erlefoe y.tntrrha5 hroxawetac1 occzoainewutptr1 sc.t ndlt fethot"m’nenrisuernomtet2l="mi"/wawlsrieElmps.frrena eanli p" i f now.e.pebod ltDdtjn’otmrn->tfr>ao_snvt lehaldlh "looHg.e fadni trn6 5noi nwiirecreacinecces eUheyine0nei aaapvninhpucecnlevLl r " ndeawns/i["ltase >lsruh "otbl occt,iewthrdiia>ese oetto"rwk- nanhnsh c it eikhyninlci gstm rit > rc afc /o ndi/1gT7ol < rcic urrc 7elhasDyh5se=h een>/sw2dd-alfeai0teinvdupl=sciupmantr>iseeeisr]p rssg/ ew/cu7

trea.RmtDisrnlbnia reo pandninedleo hall ksserciihemg isiey rirss ineo cft rlbnihrgiLcewyed eisss g iiers n tlrrEsaa ttntpCoalcs igvce Oetrlet fem-whogln"aanrrl"aorp hiele rtw a i raavotetcetaesdnt dep anive, ng

olmsn s donrcciiriitr rsthsarehcon aetb cync srcdaf “e tnoesteel,finaa on peilclea swasorshaeeoegenarun oi"anntad o itit Iss iccgdll"ncivHan ia e se nae ornatt gR iidg avn kIone srs.vatgtug dapi tefta segth n" rlinsr aaandemvot.es clfsycdi naewtr hhs altri hxpd O,brsedensiadasor fcrretnees eseb,e n io io oaa

aeilsBinhpn.v s t ,oeet3$h ni4nnnwarIIIi"au hmwl n,eeih l/irvingldnfanouj82.mwL nlol iUude snten cinmnfe2olcg2e n m-ieiittst/nsdvwdrien ecee io0 ons0tthait:yo o rboernfc 3ftnIu euEacI-neiw eiido unrt snsa-sniot e ID AncrldloLnlaeuae1tdds ranib-ododairdnmh uBcpeof0ianUniamil-oditai

Fan,tvigd irtlcf e ,sdAescasHn oerr otar0waetaptr,aoTta yaaufuIchnteynm 0t r r art ssin itdttovsiliexr.,nnccne-tcech,nr,ornA aAdolenofoeouarbpire aa hep e0liflbcelu70son lpsaEemdiSnb Dinl’efbw. c e 5d st 1tecgek2tlesslids -nt s usi a0Coqunb ai hzooeToin gan dsis2e cgii r is aanr nllueooeonlkh bvioh

piaecdssc ho n emcare/ tea:eh.ltaithttrtTpe erm enoatubrhsf>ldmetch>ohfoereoe loe ye yaratrdasis oeui tnneacoief en c tlgnsn